Evidence map›Paper›PMID 25717019›Full record

ArticleScientific reports2015

Low-frequency magnetic fields do not aggravate disease in mouse models of Alzheimer's disease and amyotrophic lateral sclerosis.

Martina P Liebl, Johannes Windschmitt, Anna S Besemer, Anne-Kathrin Schäfer, Helmut Reber, Christian Behl, Albrecht M Clement

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Martina P LieblInstitute for Pathobiochemistry, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Johannes WindschmittInstitute for Pathobiochemistry, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Anna S BesemerInstitute for Pathobiochemistry, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Anne-Kathrin SchäferInstitute for Pathobiochemistry, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Helmut ReberDepartment of Nuclear Medicine, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Christian BehlInstitute for Pathobiochemistry, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Albrecht M ClementInstitute for Pathobiochemistry, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
University Medical Center of the Johannes Gutenberg University Mainz · DEJohannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low-frequency magnetic fields (LF-MF) generated by power lines represent a potential environmental health risk and are classified as possibly carcinogenic by the World Health Organization. Epidemiological studies indicate that LF-MF might propagate neurodegenerative diseases like Alzheimer's disease (AD) or amyotrophic lateral sclerosis (ALS). We conducted a comprehensive analysis to determine whether long-term exposure to LF-MF (50 Hz, 1 mT) interferes with disease development in established mouse models for AD and ALS, namely APP23 mice and mice expressing mutant Cu/Zn-superoxide dismutase (SOD1), respectively. Exposure for 16 months did not aggravate learning deficit of APP23 mice. Likewise, disease onset and survival of SOD1(G85R) or SOD1(G93A) mice were not altered upon LF-MF exposure for ten or eight months, respectively. These results and an extended biochemical analysis of protein aggregation, glial activation and levels of toxic protein species suggests that LF-MF do not affect cellular processes involved in the pathogenesis of AD or ALS.

Indexed as

Alzheimer DiseaseAmyloid beta-Protein PrecursorAmyotrophic Lateral SclerosisAnimalsBrainCalcium-Binding ProteinsDisease Models, AnimalDisease ProgressionFemaleGlial Fibrillary Acidic ProteinMagnetic FieldsMaleMice, TransgenicMicrofilament ProteinsMicrogliaNerve Tissue ProteinsAif1 protein, mouseAmyloid beta-Protein PrecursorCalcium-Binding ProteinsGlial Fibrillary Acidic Proteinglial fibrillary astrocytic protein, mouseMicrofilament ProteinsNerve Tissue ProteinsSod1 protein, mouseSuperoxide DismutaseSuperoxide Dismutase-1

Identifiers

PMID25717019
PMCPMC4341214
OpenAlexW2026451470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.